Trial Profile
Phase I Dose Escalation Study Of UCN-01 (NSC 638850) Plus Cisplatin In Advanced Malignant Solid Tumors
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 27 Nov 2005
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; UCN 01 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 27 Nov 2005 New trial record.